Sleeping Sickness: Human African Trypanosomiasis (HAT).

Abstract

This document summarizes the problem of human African trypanosmiasis and describes the work of DNDi and its partners in developing new treatments: the search for new lead compounds, the development of the nitroimidazole fexinizadole as a new trypanocidal drug, and the introduction of nifurtimox-eflornithine combination therapy, the first new treatment developed for sleeping sickness in 25 years.

Citation

4 pp.

Sleeping Sickness: Human African Trypanosomiasis (HAT).

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.